Back to search

Article

Butyrate and related epigenetic changes link Parkinson’s disease to inflammatory bowel disease and depressive symptoms

2021-09-22

Abstract excerpt

<h4>Background</h4> The gut microbiome and its metabolites can impact brain health and are altered in Parkinson’s disease (PD) patients. It has been recently demonstrated that PD patients have reduced fecal levels of the potent epigenetic modulator butyrate and its bacterial producers. Here, we investigate whether the changes in the gut microbiome and associated metabolites are linked to PD symptoms and epigenetic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d568343-4036-52c4-abd8-7e76436bc80c
DOI
10.1101/2021.09.17.21263343
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Butyrate and related epigenetic changes link Parkinson’s disease to inflammatory bowel disease and depressive symptomsDOI 10.1101/2021.09.17.21263343
Select a neighboring publication to make it the new centre.